Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 01 Dec 2020

A Randomized Controlled Trial of a Non-pharmacological Intervention for Cancer-Related Dyspnea

in Thoracic Oncology

Patsy Yates
Janet Hardy
Alexandra Clavarino
Kwun M. Fong
Geoffrey Mitchell
Helen Skerman
Vanessa Brunelli
Isabella Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.591610

8,784 views
11 citations

Review

Published on 30 Nov 2020

Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research

in Thoracic Oncology

Kamila Wojas-Krawczyk
Tomasz Kubiatowski

Frontiers in Oncology

doi 10.3389/fonc.2020.568174

4,314 views
16 citations

Original Research

Published on 27 Nov 2020

Myasthenia Gravis Is Not an Independent Prognostic Factor of Thymoma: Results of a Propensity Score Matching Trial of 470 Patients

in Thoracic Oncology

Yirui Zhai
Yong Wei
Zhouguang Hui
Yushun Gao
Yang Luo
Zongmei Zhou
Qinfu Feng
Yuemin Li

Frontiers in Oncology

doi 10.3389/fonc.2020.583489

2,121 views
8 citations

Original Research

Published on 26 Nov 2020

Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database

in Thoracic Oncology

Liqing Zou
Tiantian Guo
Luxi Ye
Yue Zhou
Li Chu
Xiao Chu
Jianjiao Ni
Zhengfei Zhu
Xi Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.572462

4,307 views
10 citations

Case Report

Published on 26 Nov 2020

Osimertinib Resistance With a Novel EGFR L858R/A859S/Y891D Triple Mutation in a Patient With Non-Small Cell Lung Cancer: A Case Report

in Thoracic Oncology

Yanli Yang
Xing Zhang
Ruixiao Wang
Jiayue Qin
Juan Wang
Zhimin Li
Xia Song

Frontiers in Oncology

doi 10.3389/fonc.2020.542277

5,765 views
9 citations

Review

Published on 19 Nov 2020

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

in Thoracic Oncology

Tomasz Kubiatowski
Marcin Nicoś
Paweł Krawczyk

Frontiers in Oncology

doi 10.3389/fonc.2020.568081

9,069 views
1 citation

Editorial

Published on 17 Nov 2020

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

in Thoracic Oncology

Sonam Puri
Benjamin H. Lok
Natasha Leighl
Jhanelle E. Gray

Frontiers in Oncology

doi 10.3389/fonc.2020.01783

4,956 views
2 citations

Original Research

Published on 13 Nov 2020

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation

in Thoracic Oncology

Yuen Yee Cheng
Man Lee Yuen
Emma M. Rath
Ben Johnson
Ling Zhuang
Ta-kun Yu
Vesna Aleksova
Anthony Linton
Steven Kao
Candice Julie Clarke

Frontiers in Oncology

doi 10.3389/fonc.2020.579327

9,046 views
17 citations

Original Research

Published on 13 Nov 2020

The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis

in Thoracic Oncology

Olivia Lauk
Karina Bruestle
Thomas Neuer
Bianca Battilana
Thi Dan Linh Nguyen
Thomas Frauenfelder
Rolf Stahel
Walter Weder
Alessandra Curioni-Fontecedro
Isabelle Opitz

Frontiers in Oncology

doi 10.3389/fonc.2020.588563

2,146 views
2 citations

Original Research

Published on 10 Nov 2020

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study

in Thoracic Oncology

Shen Zhao
Zhen Zhang
Wenfeng Fang
Yaxiong Zhang
Zhonghan Zhang
Shaodong Hong
Yuxiang Ma
Ting Zhou
Yunpeng Yang
Yan Huang

Frontiers in Oncology

doi 10.3389/fonc.2020.587849

4,865 views
4 citations

Systematic Review

Published on 02 Nov 2020

Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Li Lv
Zhichao Liu
Yang Liu
Wenhui Zhang
Lifeng Jiang
Tingting Li
Xinyan Lu
Xuefen Lei
Wenhua Liang
Jie Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.519073

5,856 views
14 citations

Correction

Published on 30 Oct 2020

Corrigendum: Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma

in Thoracic Oncology

Fangyi Xu
Wenchao Zhu
Yao Shen
Jian Wang
Rui Xu
Chooah Outesh
Lijiang Song
Yi Gan
Cailing Pu
Hongjie Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.608365

2,182 views
5 citations

Mini Review

Published on 29 Oct 2020

Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis

in Thoracic Oncology

Daphne W. Dumoulin
Hester A. Gietema
Marthe S. Paats
Lizza E. L. Hendriks
Robin Cornelissen

Frontiers in Oncology

doi 10.3389/fonc.2020.577696

45,543 views
19 citations

Original Research

Published on 29 Oct 2020

Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer

in Thoracic Oncology

Yanyan Liu
Xinying Li
Zhucheng Yin
Ping Lu
Yifei Ma
Jindan Kai
Bo Luo
Shaozhong Wei
Xinjun Liang

Frontiers in Oncology

doi 10.3389/fonc.2020.571169

3,621 views
4 citations

Original Research

Published on 28 Oct 2020

The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/Stat 5/β-Catenin Signaling Pathway

in Thoracic Oncology

Jinrong Liao
Zeng Chen
Zongyang Yu
Tao Huang
Dan Hu
Ying Su
Zhiyong He
Changyan Zou
Lurong Zhang
Xiandong Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.585292

4,315 views
9 citations

Original Research

Published on 28 Oct 2020

Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs

in Thoracic Oncology

Chia-Hao Chang
Chih-Hsin Lee
Jen-Chung Ko
Lih-Yu Chang
Ming-Chia Lee
Jun-Fu Zhang
Jann-Yuan Wang
Jin-Yuan Shih
Chong-Jen Yu

Frontiers in Oncology

doi 10.3389/fonc.2020.583529

4,155 views
18 citations